Measles Vaccine has 6 known drug interactions based on U.S. FDA drug labeling data. 1 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Hydroxyurea, Hepatitis B Immune Globulin (Human), Human Botulinum Neurotoxin A/B Immune Globulin. Patients taking Measles Vaccine should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 6
- Major
- 1
- Moderate
- 5
Major (1)
- Measles Vaccine + Hydroxyurea— Concomitant use may potentiate vaccine virus replication and increase adverse reactions. May result in severe infections…
Moderate (5)
- Measles Vaccine + Hepatitis B Immune Globulin (Human)— Live virus vaccines should be deferred until approximately three months after administration of Hepatitis B Immune Globu…
- Measles Vaccine + Human Botulinum Neurotoxin A/B Immune Globulin— Antibodies in BabyBIG may interfere with immune response to measles vaccine; vaccination should be deferred until 6 mont…
- Measles Vaccine + Human Immunoglobulin G— Immunoglobulin may transiently impair efficacy of live attenuated measles vaccine due to interference with active antibo…
- Measles Vaccine + Immune Globulin Intravenous (Human) 10%— VIGIV may impair efficacy of live attenuated measles vaccine. Defer vaccination until approximately three months after V…
- Measles Vaccine + Tuberculin Purified Protein Derivative— Live measles vaccine may temporarily depress PPD reactivity. Tuberculin test should be given before vaccine, simultaneou…